Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
13%
Adverse Event
30%
Anti-Inflammatory Drug
26%
Antiapoptotic
9%
Antibiotics
54%
Anticoagulant Agent
19%
Antidiabetic Agent
10%
Antiinfective Agent
64%
Antimicrobial Resistance
48%
Antioxidant
32%
Atrial Fibrillation
11%
Bioavailability
37%
Breast Cancer
17%
Cardiovascular Disease
38%
Chemotherapy
14%
Chitosan
23%
Chronic Disease
18%
Clinical Trial
16%
Cohort Study
28%
Combination Therapy
19%
Community Pharmacy
22%
Comorbidity
27%
Congestive Heart Failure
13%
Controlled Release
11%
Coronavirinae
23%
COVID-19 Vaccine
11%
Cross Sectional Study
12%
Cross-Sectional Study
98%
Curcumin
11%
Cyclodextrin
17%
CYP2C9
11%
Dexibuprofen
11%
Diabetes Mellitus
56%
Diabetic Cardiomyopathy
11%
Differential Scanning Calorimetry
14%
Diseases
100%
Dosage Form
13%
Doxorubicin
10%
Drug Delivery System
15%
Drug Interaction
15%
Drug Release
17%
Drug-Drug Interaction
10%
Escherichia coli
11%
Essential Oil
10%
Eudragit
13%
Favipiravir
11%
FDA Adverse Event Reporting System
13%
Gentamicin
11%
Global Disease Burden
28%
Hemoglobin A1c
13%
Hydroxychloroquine
14%
IC50
11%
Infection
36%
Infectious Agent
10%
Inflammation
25%
Inflammatory Arthritis
12%
Liposome
9%
Liver Cell Carcinoma
11%
Malignant Neoplasm
79%
Medication Error
12%
microRNA
35%
Nanocomposite
11%
Nanoemulsion
15%
Nanomaterial
13%
Nanoparticle
28%
Neoplasm
18%
Non Insulin Dependent Diabetes Mellitus
15%
Observational Study
20%
Pandemic
19%
Parkinson's Disease
14%
Pharmacokinetic
26%
Pharmacotherapy
18%
Pharmacy Practice
14%
Phytochemical
11%
Piroxicam
11%
Poloxamer
10%
Polypharmacy
10%
Prevalence
64%
Pterostilbene
13%
Randomized Controlled Trial
12%
Resveratrol
12%
Retrospective Study
23%
Reverse Phase High Performance Liquid Chromatography
14%
Rheumatoid Arthritis
12%
Rosuvastatin
11%
SARS Coronavirus
20%
Scanning Electron Microscopy
11%
Side Effect
24%
Silibinin
11%
Superoxide Dismutase
10%
Surgical Infection
13%
Surgical Prophylaxis
13%
Syndrome
14%
Tablet
33%
Toll Like Receptor 4
10%
Transcription Factor Nrf2
13%
Untranslated RNA
10%
Vancomycin
20%
Warfarin
51%
Zeta Potential
10%
Nursing and Health Professions
Anticoagulant Agent
5%
Anticoagulant Therapy
8%
Anticoagulation
7%
Antiinfective Agent
17%
Antimicrobial Resistance
17%
Antimicrobial Stewardship
28%
Blood Pressure
11%
Cardiovascular Disease
10%
Chronic Disease
12%
Clinical Outcome
7%
Cohort Analysis
17%
Comorbidity
7%
Confidence Interval
7%
Congestive Heart Failure
8%
Cost Effectiveness Analysis
14%
Cross-Sectional Study
63%
Diabetes Mellitus
36%
Diseases
38%
Drug Therapy
8%
Emergency Ward
11%
General Practitioner
10%
Hazard Ratio
5%
Health Care
11%
Health Care Cost
16%
Health Care Personnel
45%
Health Care Utilization
11%
Hemoglobin A1c
6%
Hospital Readmission
5%
Infection
8%
Inferential Statistics
8%
Inflammatory Arthritis
14%
Intensive Care Unit
12%
International Normalized Ratio
7%
Linear Regression Analysis
6%
Logistic Regression Analysis
5%
Malignant Neoplasm
6%
Medication Compliance
19%
Medication Error
10%
Medication Therapy Management
9%
Meta Analysis
12%
Multiple Linear Regression Analysis
6%
Non Insulin Dependent Diabetes Mellitus
9%
Odds Ratio
8%
Outpatient Department
5%
Patient Attitude
11%
Patient Compliance
12%
Patient with Diabetes
17%
Patient with Type 2 Diabetes
10%
Patient-Reported Outcome
5%
Pharmacy Student
11%
Physical Disease by Body Function
5%
Polypharmacy
7%
Practice Guideline
6%
Prevalence
14%
Primary Health Care
9%
Professional Standard
8%
Propensity Score
13%
Quality of Life
61%
Rheumatoid Arthritis
14%
Sample Size
5%
Self Care
5%
Study Participant
5%
Systematic Review
19%
Telemedicine
9%
Tertiary Care Center
17%
Warfarin
28%
World Health Organization
10%
Medicine and Dentistry
Acute Myeloid Leukemia
5%
Angiogenesis
5%
Antibiotic Resistance
5%
Antibiotics
6%
Anticarcinogen
5%
Antiinfective Agent
10%
Apoplexy
6%
Autophagy
5%
Breast Cancer
11%
Cancer
5%
Cancer Cell
12%
Cancer Therapy
17%
Cardiovascular Disease
10%
Cardiovascular System
7%
Cell Death
6%
Chronic Disease
9%
Combination Therapy
10%
Community Pharmacy
5%
Complementary and Alternative Medicine
7%
Counseling
5%
COVID-19
39%
COVID-19 Vaccination
7%
Cross Sectional Study
16%
Diabetes
24%
Diabetes Mellitus
21%
Diseases
15%
Drug Therapy
11%
Emergency Department
8%
Epithelial Mesenchymal Transition
7%
Exosome
7%
Global Disease Burden
18%
Health Care
6%
Health Care Cost
23%
Health Care Management
6%
Hemoglobin A1c
8%
Hepatocellular Carcinoma
7%
Infection
12%
Insulin Resistance
6%
Lung Cancer
7%
Malignant Neoplasm
29%
Maturity Onset Diabetes of the Young
13%
Medicine
5%
Metastatic Carcinoma
13%
microRNA
25%
Neoplasm
12%
Odds Ratio
7%
Ophthalmology
7%
Pathogen
5%
Patient Care
5%
Patient with Diabetes
7%
Patient with Type 2 Diabetes
10%
Pediatrics
8%
Pediatrics Patient
6%
Phytochemical
5%
Polycystic Ovarian Syndrome
6%
Polycystic Ovary Syndrome
5%
Prevalence
8%
Primary Health Care
7%
Programmed Cell Death
18%
Propensity Score Matching
6%
Prostate Cancer
7%
Public Health
5%
Quality of Life
12%
Retrospective Cohort Study
12%
Retrospective Study
5%
Systematic Review
14%
Tertiary Care
15%
Tocilizumab
7%
Tumor Progression
8%
Virus
5%